Glenmark Pharmaceuticals on Thursday informed the exchanges of the launch of Nourkrin, used to treat hair loss, in the Russian market.
The product catering to both male and female patients will be exclusively marketed in Russia by Glenmark Impex LLC, a subsidiary of the company, under a licensing agreement with Denmark’s Pharma Medico ApS.
Glenmark launched Nourkrin Woman in India early this year. Shares of Glenmark Pharma closed 0.20 per cent higher at ₹622.20 on the BSE.